Replimune Group, Inc. (REPL)
NASDAQ·Healthcare·Biotechnology
$12.67
+6.47%
Mkt Cap $940.40M
Analyst Ratings
Buy
2
Hold
6
Sell
2
Price Target (18 analysts)
$14.00
Range $12.00 – $16.00
Implied Upside
+10.5%
Consensus $14.00 vs current $12.67
NASDAQ·Healthcare·Biotechnology
$12.67
+6.47%
Mkt Cap $940.40M
Buy
2
Hold
6
Sell
2
Price Target (18 analysts)
$14.00
Range $12.00 – $16.00
+10.5%
Consensus $14.00 vs current $12.67